Pharmacogenomics (PGx) Testing for Military Readiness Pilot
SAM.GOV Due: May 14, 2025 at 04:00 PM UTC
In-Active Presolicitation Source Url

Summary

The opportunity for Pharmacogenomics (PGx) Testing for Military Readiness Pilot is a presolicitation from the Medical Technology Enterprise Consortium (MTEC) aimed at establishing a pilot program to enhance the use of pharmacogenomics within the Military Health System (MHS). This initiative seeks to improve healthcare delivery and outcomes for military personnel by developing protocols for routine PGx testing, which will provide actionable insights for medical treatment. Contractors with expertise in clinical pharmacogenomics, particularly those experienced in implementing PGx in various medical conditions, are encouraged to bid. The program will leverage electronic health records to track patient outcomes and optimize medication management, ultimately aiming to prevent adverse drug reactions and improve treatment efficacy for Active-Duty service members.
Description

The Medical Technology Enterprise Consortium (MTEC) is excited to post this pre-announcement for a Request for Project Proposals (RPP) focused on establishing a pilot program to demonstrate the enhanced use of pharmacogenomics (PGx) in the Military Health System (MHS) to aid in the treatment for

Entities
DOD
Department of Defense
DHA(
Defense Health Agency
NAICS
541715
Set Aside
None
Place of Performance
Frederick , Maryland 21702
Point of Contact
Full Name Email Phone Type
Dr. Lauren Palestrini [email protected]. primary